Literature DB >> 23097327

Functional limitations due to axial and peripheral joint impairments in patients with ankylosing spondylitis: are focused measures more informative?

Siddharth Bethi1, Abhijit Dasgupta, Michael H Weisman, Thomas J Learch, Lianne S Gensler, John C Davis, John D Reveille, Michael M Ward.   

Abstract

OBJECTIVE: Functional limitations in ankylosing spondylitis (AS) may be due to peripheral joint or axial involvement. To determine if the Bath Ankylosing Spondylitis Functional Index (BASFI), an axial-focused measure, can detect limitations related to peripheral joint involvement equally as well as the Health Assessment Questionnaire modified for the spondyloarthropathies (HAQ-S), a peripheral arthritis-focused measure, and vice versa, we compared associations of each questionnaire with spinal and hip range of motion, peripheral arthritis, and enthesitis in patients with AS.
METHODS: We examined patients every 4-6 months in this prospective longitudinal study. We used mixed linear models to analyze the associations between 10 physical examination measures and the BASFI and HAQ-S.
RESULTS: We studied 411 patients for a median of 1.5 years (median 3 visits). In multivariate analyses, cervical rotation, chest expansion, lateral thoracolumbar flexion, hip motion, tender joint count, and tender enthesis count were equally strongly associated with the BASFI and HAQ-S. Peripheral joint swelling was more strongly associated with the HAQ-S. Individual items of the BASFI were more likely than items of the HAQ-S to be associated with unrelated physical examination measures (e.g., the association between difficulty rising from a chair and cervical rotation), which may have diminished the axial/peripheral distinction for the BASFI.
CONCLUSION: The BASFI and HAQ-S had similar associations with impairments in axial measures, while the HAQ-S had stronger associations with the number of swollen peripheral joints. The HAQ-S should be considered for use in studies focused on spondyloarthritis with peripheral joint involvement.
Copyright © 2013 by the American College of Rheumatology.

Entities:  

Mesh:

Year:  2013        PMID: 23097327      PMCID: PMC3567248          DOI: 10.1002/acr.21878

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  38 in total

1.  Risk factors for functional limitations in patients with long-standing ankylosing spondylitis.

Authors:  Michael M Ward; Michael H Weisman; John C Davis; John D Reveille
Journal:  Arthritis Rheum       Date:  2005-10-15

2.  [Validation of the Italian versions of the Bath Ankylosing Spondylitis Functional Index (BASFI) and the Dougados Functional Index (DFI) in patients with ankylosing spondylitis].

Authors:  F Salaffi; A Stancati; A Silvestri; M Carotti; W Grassi
Journal:  Reumatismo       Date:  2005 Jul-Sep

3.  ICF based comparison of disease specific instruments measuring physical functional ability in ankylosing spondylitis.

Authors:  T Sigl; A Cieza; D van der Heijde; G Stucki
Journal:  Ann Rheum Dis       Date:  2005-04-20       Impact factor: 19.103

4.  Clinimetric evaluation of the bath ankylosing spondylitis metrology index in a controlled trial of pamidronate therapy.

Authors:  Edwin Jauregui; Barbara Conner-Spady; Anthony S Russell; Walter P Maksymowych
Journal:  J Rheumatol       Date:  2004-12       Impact factor: 4.666

5.  Impairment and disability in the aged.

Authors:  A M Jette; L G Branch
Journal:  J Chronic Dis       Date:  1985

6.  The Turkish versions of the Bath Ankylosing Spondylitis and Dougados Functional Indices: reliability and validity.

Authors:  Altinay Goksel Karatepe; Yesim Akkoc; Servet Akar; Yesim Kirazli; Nurullah Akkoc
Journal:  Rheumatol Int       Date:  2004-07-10       Impact factor: 2.631

7.  Scientific and clinical problems in indexes of functional disability.

Authors:  A R Feinstein; B R Josephy; C K Wells
Journal:  Ann Intern Med       Date:  1986-09       Impact factor: 25.391

8.  The Turkish version of the Bath Ankylosing Spondylitis Functional Index: reliability and validity.

Authors:  Huseyin T E Ozer; Tunay Sarpel; Bozkurt Gulek; Z Nazan Alparslan; Eren Erken
Journal:  Clin Rheumatol       Date:  2004-08-31       Impact factor: 2.980

9.  Evaluation of diagnostic criteria for ankylosing spondylitis: a comparison of the Rome, New York and modified New York criteria in patients with a positive clinical history screening test for ankylosing spondylitis.

Authors:  H S Goie The; M M Steven; S M van der Linden; A Cats
Journal:  Br J Rheumatol       Date:  1985-08

10.  Late-onset peripheral joint disease in ankylosing spondylitis.

Authors:  M D Cohen; W W Ginsburg
Journal:  Ann Rheum Dis       Date:  1982-12       Impact factor: 19.103

View more
  3 in total

Review 1.  A registry of ankylosing spondylitis registries and prospects for global interfacing.

Authors:  John D Reveille
Journal:  Curr Opin Rheumatol       Date:  2013-07       Impact factor: 5.006

2.  [Long version on the S3 guidelines for axial spondyloarthritis including Bechterew's disease and early forms, Update 2019 : Evidence-based guidelines of the German Society for Rheumatology (DGRh) and participating medical scientific specialist societies and other organizations].

Authors:  U Kiltz; J Braun; A Becker; J-F Chenot; M Dreimann; L Hammel; A Heiligenhaus; K-G Hermann; R Klett; D Krause; K-F Kreitner; U Lange; A Lauterbach; W Mau; R Mössner; U Oberschelp; S Philipp; U Pleyer; M Rudwaleit; E Schneider; T L Schulte; J Sieper; A Stallmach; B Swoboda; M Winking
Journal:  Z Rheumatol       Date:  2019-12       Impact factor: 1.372

3.  The Clinical and MRI Effect of TNF-α Inhibitors in Spondyloarthritis Patients With Hip Involvement: A Real-World Observational Clinical Study.

Authors:  Kui Zhang; Yan Zheng; Qing Han; Ying Liu; Weitao Wang; Jin Ding; Yan Wang; Bei Zhang; Junfeng Jia; Minwen Zheng; Zhaohui Zheng; Ping Zhu
Journal:  Front Immunol       Date:  2021-09-29       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.